Peter Greenleaf
Chief Executive Officer chez AURINIA PHARMACEUTICALS INC.
Fortune : 8 M $ au 31/03/2024
Profil
Peter S.
Greenleaf currently works at Aurinia Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2019, Maryland Venture Fund, as Chairman, Revolo Biotherapeutics Ltd., as Chairman from 2020, Pharmaceutical Research & Manufacturers of America, as Director, ValenzaBio, Inc., as Director, and Petrichor Healthcare Capital Management LP, as Advisory.
Mr. Greenleaf also formerly worked at Histogenics Corp., as President, Chief Executive Officer & Director from 2013 to 2014, Sucampo Pharmaceuticals LLC, as Chairman & Chief Executive Officer from 2016 to 2018, BioDelivery Sciences International, Inc., as Chairman from 2018 to 2022, Antares Pharma, Inc., as Independent Director from 2018 to 2022, Mast Therapeutics, Inc., as Independent Director, Oldtech, Inc., as Director, Kiora Pharmaceuticals, Inc., as Director from 2018 to 2020, Biotechnology Innovation Organization, as Director, Melinta Subsidiary Corp., as Director, Tech Council of Maryland, Inc., as Director, LigoCyte Pharmaceuticals, Inc., as Director, Mirna Therapeutics, Inc., as Independent Director, Corridor Pharmaceuticals, Inc., as Director, Avalo Therapeutics, Inc., as Director from 2019 to 2020, Savara, Inc., as Director, OS Therapies, Inc., as Director, Centocor, Inc., as VP-US Gastroenterology Commercial Group, MedImmune LLC, as President from 2006 to 2013, US Healthcare, Inc., as Principal, Hallmark Cards, Inc., as Principal, MedImmune Ventures, Inc., as President from 2010 to 2013, Roche Diagnostics Corp., as Principal from 1996 to 1998, and The University of Maryland Baltimore Foundation, Inc., as Trustee.
Mr. Greenleaf received his Masters Business Admin degree from St. Joseph's University and undergraduate degree from Western Connecticut State University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
06/03/2024 | 1 522 114 ( 1,05% ) | 8 M $ | 31/03/2024 |
Postes actifs de Peter Greenleaf
Sociétés | Poste | Début |
---|---|---|
AURINIA PHARMACEUTICALS INC. | Chief Executive Officer | 29/04/2019 |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is an independent private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | Consultant / Advisor | - |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Chairman | 17/12/2020 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | - |
Maryland Venture Fund
Maryland Venture Fund Investment ManagersFinance Maryland Venture Fund is an evergreen fund seeks investment opportunities in companies located in the United States. The fund focuses on companies operating in the fields of technology. It provides in seed and early stage capital transactions with an investment size ranging from $500K to $2 million. | Chairman | - |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Director/Board Member | - |
Anciens postes connus de Peter Greenleaf
Sociétés | Poste | Fin |
---|---|---|
ANTARES PHARMA, INC. | Director/Board Member | 24/05/2022 |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Chairman | 22/03/2022 |
AVALO THERAPEUTICS, INC. | Chief Executive Officer | 15/04/2019 |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Peter Greenleaf
St. Joseph's University | Masters Business Admin |
Western Connecticut State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
KIORA PHARMACEUTICALS, INC. | Health Technology |
AVALO THERAPEUTICS, INC. | Health Technology |
AURINIA PHARMACEUTICALS INC. | Health Technology |
SAVARA INC. | Health Technology |
Entreprise privées | 25 |
---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
US Healthcare, Inc.
US Healthcare, Inc. Medical/Nursing ServicesHealth Services Part of CVS Health Corp., US Healthcare, Inc. is a private company that provides healthcare services for individuals, families, and businesses. US Healthcare, Inc. is based in Blue Bell, PA. US Healthcare was acquired by Aetna, Inc., part of CVS Health Corp. from November 29, 2018 on July 19, 1996 for $8,114.05 million. The company was founded by Benad Goldwasser, Angelo Masciantonio. | Health Services |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Hallmark Cards, Inc.
Hallmark Cards, Inc. Consumer SundriesConsumer Non-Durables Hallmark Cards, Inc. sells greeting card products, art supplies and stationery to retail outlets. It offers greeting cards, holiday cards, gift wrap, story books, ornaments and stationary products. The firm offers art tools, crafting activities, and creative toys for kids. The company was founded by Joyce Clyde Hall in 1910 and is headquartered in Kansas City, MO. | Consumer Non-Durables |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Finance |
Histogenics Corp.
Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Tech Council of Maryland, Inc.
Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
LigoCyte Pharmaceuticals, Inc. | Health Technology |
The University of Maryland Baltimore Foundation, Inc. | Miscellaneous |
Maryland Venture Fund
Maryland Venture Fund Investment ManagersFinance Maryland Venture Fund is an evergreen fund seeks investment opportunities in companies located in the United States. The fund focuses on companies operating in the fields of technology. It provides in seed and early stage capital transactions with an investment size ranging from $500K to $2 million. | Finance |
Corridor Pharmaceuticals, Inc.
Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Health Technology |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is an independent private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | Finance |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Commercial Services |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Health Technology |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |